@pfeifer1982
You wrote:
", it makes it potentially easier for the FDA to agree and not lose face regarding CRL #1 and #2, as they can claim that they led to an improved potency assay etc."
That is what I was referring to when I wrote this -
"Premises about saving face - only make sense if one supposed someone has to save face. "
I was suggesting to you, the FDA had not lost any face, so they didn't need to save any.
@pfeifer1982You wrote:", it makes it potentially easier for the...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.060(5.85%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.10 | $1.02 | $6.406M | 6.038M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 313712 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.08 |
Change
0.060 ( 5.29 %) |
||||
| Open | High | Low | Volume | ||
| $1.03 | $1.10 | $1.02 | 928883 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| MSB (ASX) Chart |